Berenberg Bank Adjusts Recursion Pharmaceuticals' Price Target to $38 From $36, Maintains Buy Rating

06/22/2022 | 08:02am

This article is reserved for subscribers A "one-stop shopping" service for investors The best opportunities, portfolios, and screeners Discover